Acting Normal: US FDA's Unusual Interim Period Drags On

During one of his first public appearances after taking over as acting commissioner of the US Food and Drug Administration, Ned Sharpless jokingly acknowledged a predecessor in the audience by claiming to be just the second person to pull of the "von Eschenbach maneuver”: moving to head FDA after serving as the Director of the National Cancer Institute.